210 results on '"Finelli, Carmine"'
Search Results
2. Reduced Pharmacological Intervention of Prehospital Services for Acute Alcohol Intoxication during the COVID-19 Pandemic in A Large District of Southern Italy
3. Diet Recommendations
4. Contribution to molecular nutrition: Carbohydrates
5. Contributors
6. Molecular Mechanisms and Mediators of Hepatotoxicity Resulting from an Excess of Lipids and Non-Alcoholic Fatty Liver Disease
7. Orexin-A represses satiety-inducing POMC neurons and contributes to obesity via stimulation of endocannabinoid signaling
8. Characterization of Student Drinking Behaviors at the Beginning of the First Academic Year at One University in Southern Italy
9. Preliminary data on the relationship between circulating levels of Sirtuin 4, anthropometric and metabolic parameters in obese subjects according to growth hormone/insulin-like growth factor-1 status
10. "Metabolic Syndrome, Obesity and Irisin: State of the Art"
11. "Metabolic Syndrome and Longevity: A Framework of Situation"
12. Gut Microbiota, NAFLD and COVID-19: A Possible Interaction
13. Lipids Nutrition and Epigenetic Modification in Obesity-Related Co-Morbitities * *All authors equally contributed to draft the manuscript. All authors gave final approval of the version to be published. Disclosure statement: The authors declare that there are no conflicts of interest.
14. Lipids, Low-Grade Chronic Inflammation and NAFLD
15. List of Contributors
16. Diet Recommendations
17. "Metabolic Syndrome and Berberine: A Framework of Situation"
18. Is Co-Administration Curcumin and Piperine a Benefit in Preventing Metabolic Syndrome?
19. Metabolic Syndrome, Alzheimer’s Disease, and Covid 19: A Possible Correlation
20. Should visceral fat, strictly linked to hepatic steatosis, be depleted to improve survival?
21. Beyond Nutrition Is There Any Role for Physical Activity in Nonalcoholic Fatty Liver Disease Therapy?
22. "Is Pentraxin 3 A Marker in Pathogenesis of Metabolic Syndrome?"
23. "Metabolic Syndrome and Fetuin-A: Framework of Situation"
24. "Long Term Care, Alzheimer’s Disease and COVID-19: Framework of Situation"
25. Noninvasive Evaluation of Abdominal Fat and Liver Changes Following Progressive Weight Loss in Severely Obese Patients Treated with Laparoscopic Gastric Bypass
26. "Long Term Care and Vitamin D Supplementation in COVID-19 ERA"
27. Metabolic and Nutritional Status Changes After 10% WeightLoss in Severely Obese Patients Treated with Laparoscopic Surgery vs Integrated Medical Treatment
28. Obesity and the Frailty Syndrome at Period of Covid-19
29. Micro RNAS And Potential Role as Obesity Predictors At Period Of Covid-19
30. A Possible Correlation between Obesity, Covid-19 and Vitamin D
31. Obesity, Physical Activity and Covid-19: Current Condition
32. Obesity, COVID-19 and Immunotherapy: the Complex Relationship!
33. Food Safety, COVID-19 and Laboratory Testing
34. Obesity and immunotherapy: the surprisingly positive association!
35. Obesity and adenovirus 36: a possible correlation?
36. Variants of uncoupling protein-2 gene and obesity: interaction with peroxisome proliferator-activated receptorγ2
37. Are hepatic steatosis and carotid intima media thickness associated in obese patients with normal or slightly elevated gamma-glutamyl-transferase?
38. Il diritto umano di accesso all'acqua e la sua applicazione ai conflitti armati
39. “Obesity paradox” or “metabolically benign obesity”?
40. Young adult obese subjects with and without insulin resistance: what is the role of chronic inflammation and how to weigh it non-invasively?
41. WITHDRAWN: Dealing with visceral fat reduction to slow the progression of NAFLD
42. Nesfatin-1: role as possible new anti-obesity treatment
43. Corrigendum to “Circulating Levels of Sirtuin 4, a Potential Marker of Oxidative Metabolism, Related to Coronary Artery Disease in Obese Patients Suffering from NAFLD, with Normal or Slightly Increased Liver Enzymes”
44. Corrigendum to “Sequence Analysis of the UCP1 Gene in a Severe Obese Population from Southern Italy”
45. The Mediterranean diet: an “evergreen” diet
46. WITHDRAWN: Could some epigenetic modifications hold the key to opposing the metabolic syndrome?
47. WITHDRAWN: Dealing with visceral fat reduction to slow the progression of NAFLD
48. Nesfatin-1
49. Nonalcoholic fatty liver disease, diet and gut microbiota
50. Mitochondrial haplogroups and obesity in patients from South Italy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.